×

Kim SH, Cho BC, Choi HJ, Chung KY, Kim DJ, Park MS, Kim SK, Chang J, Shin SJ et al: The number of residual metastatic lymph nodes following neoadjuvant chemotherapy predicts survival in patients with stage III NSCLC. Lung Cancer Dec 21, 2007

Choi HJ, Cho BC, Shin SJ, et al: Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy. Cancer Chemother Pharmacol 61:309-13, 2008

Cho BC, Im CK, Park MS, Kim SK, Chang J, Park JP, Choi HJ, Kim YJ, Shin SJ et al: Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib, J Clin Oncol, 2007, 2528-33
Jeung HC, Rha SY, Shin SJ, et al: A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status. Br J Cancer 97:458-63, 2007

Shin SJ, Jeung HC, Ahn JB, et al: Capecitabine and doxorubicin combination chemotherapy as salvage therapy in pretreated advanced gastric cancer. Cancer Chemother Pharmacol, 2007

Sohn JH, Choi HJ, Chang J, Shin SJ et al: A phase II trial of fractionated irinotecan plus carboplatin for previously untreated extensive-disease small cell lung cancer. Lung Cancer 54:365-70, 2006

Lee KH, Shin SJ, Kim KO, et al: Relationship between E-cadherin, matrix metalloproteinase-7 gene expression and clinicopathological features in gastric carcinoma. Oncol Rep 16:823-30, 2006

Kim KO, Lee HY, Chun SH, Shin SJ et al: Clinical overview of extrapulmonary small cell carcinoma. J Korean Med Sci 21:833-7, 2006

Shin SJ, Kim KO, Kim MK, et al: Expression of E-cadherin and uPA and their association with the prognosis of pancreatic cancer. Jpn J Clin Oncol 35:342-8, 2005

Shin SJ, Chun SH, Kim KO, et al: Myelodysplastic syndrome with complex karyotypic abnormality in a patient with Waldenstrom's acroglobulinemia after sequential treatment with chlorambucil and fludarabine. Jpn J Clin Oncol 35:622-5, 2005

Shin SJ, Chun SH, Kim KO, et al: The efficacy of paclitaxel and cisplatin combination chemotherapy for the treatment of metastatic or recurrent gastric cancer: a multicenter phase II study. Korean J Intern Med 20:135-40, 2005

Shin SJ, Kim MK, Lee KH, Hyun MS,Bae SH, Ryoo HM, et al: The Efficacy of Docetaxel and Cisplatin Combination Chemotherapy for the Treatment of Advanced Gastric Cancer after Failing to 5-FU based Chemotherapy: a Single-Center Phase II Study. Cancer Research and Treatment, 2004

Effect of Radiotherapy Combined With Pembrolizumab on Local Tumor Control in Mucosal Melanoma Patients
FRONTIERS IN ONCOLOGY 9/ :835-,2019

Treatment Outcomes of Re-irradiation in Locoregionally Recurrent Rectal Cancer and Clinical Significance of Proper Patient Selection
FRONTIERS IN ONCOLOGY 9/Issue J :Article number 529-,2019

Screening for Lung Cancer Using Low-dose Chest Computed Tomography in Korean Long-term Colorectal Cancer Survivors
Journal of Cancer Prevention 24/1 :48-53,2019

The role of endoscopic evaluation for radiation proctitis in patients receiving intermediate-dose postoperative radiotherapy for rectal cancer
JAPANESE JOURNAL OF CLINICAL ONCOLOGY 48/11 :988-994,2018

CpG Island Methylator Phenotype and Methylation of Wnt Pathway Genes Together Predict Survival in Patients with Colorectal Cancer
YONSEI MEDICAL JOURNAL 59/5 :588-594,2018

IL21 Therapy Combined with PD-1 and Tim-3 Blockade Provides Enhanced NK Cell Antitumor Activity against MHC Class I-Deficient Tumors
CANCER IMMUNOLOGY RESEARCH 6/6 :685-695,2018

Activation of NKT Cells in an Anti-PD-1-Resistant Tumor Model Enhances Antitumor Immunity by Reinvigorating Exhausted CD8 T Cells.
CANCER RESEARCH 78/18 :5,315-5,326,2018

Prognoses and Clinical Outcomes of Primary and Recurrent Uveal Melanoma
CANCER RESEARCH AND TREATMENT 50/4 :1238-1251,2018

Genetic Alterations among Korean Melanoma Patients Showing Tumor Heterogeneity: A Comparison between Primary Tumors and Corresponding Metastatic Lesions.
CANCER RESEARCH AND TREATMENT 50/4 :1,378-1,387,2018

Predictive Nomogram for Recurrence of Stage I Colorectal Cancer After Curative Resection
CLINICAL COLORECTAL CANCER 17/3 :513-518,2018

Mapping of lateral pelvic lymph node recurrences in rectal cancer: a radiation oncologist's perspective
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 144/6 :1119-1128,2018

YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma
CANCER IMMUNOLOGY RESEARCH 6/3 :255-266,2018

A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors
INVESTIGATIONAL NEW DRUGS 35/6 :773-781,2017

Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition.
ONCOGENE 36/23 :3,334-3,345,2017

IL-21-mediated reversal of NK cell exhaustion facilitates anti-Tumour immunity in MHC class I-deficient tumours
NATURE COMMUNICATIONS 8/15776 :1-14,2017

Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery
BMC CANCER 17/615 :615-625,2017

Reduced pelvic field sparing anastomosis for postoperative radiotherapy in selected patients with mid?upper rectal cancer
JOURNAL OF RADIATION RESEARCH 58/4 :559-566,2017

Quality of life among Korean gastrointestinal cancer survivors
EUROPEAN JOURNAL OF ONCOLOGY NURSING 30/ :15-21,2017

Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer
ONCOLOGY LETTERS 14/2 :2,385-2,392,2017

Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer
ANNALS OF SURGICAL ONCOLOGY 24/1 :227-235,2017

Telomerase reverse transcriptase (TERT) promoter mutations in Korean melanoma patients
AMERICAN JOURNAL OF CANCER RESEARCH 7/1 :134-138,2017

Ipilimumab Real-World Efficacy and Safety in Korean Melanoma Patients from the Korean Named-Patient Program Cohort
CANCER RESEARCH AND TREATMENT 49/1 :44-53,2017

Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer
ANNALS OF SURGICAL ONCOLOGY 23/ :928-935,2016

Impact of p16 expression in oropharyngeal cancer in the postoperative setting: the necessity of re-evaluating traditional risk stratification.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY 46/10 :91-918,2016

Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Surrogate Biomarker for Bevacizumab in Colorectal Cancer Liver Metastasis: A Single-Arm, Exploratory Trial
CANCER RESEARCH AND TREATMENT 48/4 :1,210-1,221,2016

Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers
BRITISH JOURNAL OF CANCER 115/1 :25-33,2016

A New Practical Desensitization Protocol for Oxaliplatin-Induced Immediate Hypersensitivity Reactions: A Necessary and Useful Approach
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY 26/3 :168-176,2016

High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 142/9 :2051-2059,2016

Upfront Systemic Chemotherapy and Short-Course Radiotherapy with Delayed Surgery for Locally Advanced Rectal Cancer with Distant Metastases: Outcomes, Compliance, and Favorable Prognostic Factors
PLOS ONE 11/8 :e0161475-,2016

Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: Implications for individualized therapy
ONCOTARGET 7/28 :44608-44620,2016

A phase II study of preoperative mFOLFOX6 with short-course radiotherapy in patients with locally advanced rectal cancer and liver-only metastasis
RADIOTHERAPY AND ONCOLOGY 118/2 :369-374,2016

p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer
CANCER RESEARCH AND TREATMENT 48/1 :208-215,2016

A Randomized Phase 2 Study of Neoadjuvant Chemoradiaton Therapy With 5-Fluorouracil/Leucovorin or Irinotecan/S-1 in Patients With Locally Advanced Rectal Cancer
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 93/5 :1015-1022,2015

Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine
CANCER RESEARCH AND TREATMENT 74/4 :781-789,2015

Clinical Implications from a Single-Center Study of Colorectal Adenocarcinoma in Transplant Recipients
ONCOLOGY 88/4 :195-200,2015

Novel Methods for Clinical Risk Stratification in Patients with Colorectal Liver Metastases
CANCER RESEARCH AND TREATMENT 47/2 :242-250,2015

Incorporation of Radiotherapy in the Multidisciplinary Treatment of Isolated Retroperitoneal Lymph Node Recurrence from Colorectal Cancer
ANNALS OF SURGICAL ONCOLOGY 22/5 :1520-1526,2015

PINCH-2 presents functional copy number variation and suppresses migration of colon cancer cells by paracrine activity
INTERNATIONAL JOURNAL OF CANCER 136/10 :2273-2283,2015

Incidence and Survival of Pediatric Soft Tissue Sarcomas: Comparison between Adults and Children
CANCER RESEARCH AND TREATMENT 47/1 :9-17,2015

Pediatric Patients with Refractory Central Nervous System Tumors: Experiences of a Clinical Trial Combining Bevacizumab and Temsirolimus
ANTICANCER RESEARCH 34/4 :1939-1945,2014

High KLF4 level in normal tissue predicts poor survival in colorectal cancer patients
WORLD JOURNAL OF SURGICAL ONCOLOGY 12/- :232-238,2014

Clinical significance of primary tumor resection in colorectal cancer patients with synchronous unresectable metastasis.
JOURNAL OF SURGICAL ONCOLOGY 110/2 :214-221,2014

A phase II open-label randomized multicenter trial of TSU-68 in combination with S-1 and oxaliplatin versus S-1 in combination with oxaliplatin in patients with metastatic colorectal cancer
INVESTIGATIONAL NEW DRUGS 32/3 :561-568,2014

Predicting the pathologic response of locally advanced rectal cancer to neoadjuvant concurrent chemoradiation using enzyme linked immunosorbent assays (ELISAs) for biomarkers
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 140/3 :399-409,2014

Better Outcome of XELOX Chemotherapy in Patients with Advanced Intestinal-Type Adenocarcinoma of the Ampulla of Vater
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE 231/ :21-28,2013

Quantitation and pharmacokinetics of 1,4-diamino-2,3-dicyano-1,4-bis (2-aminophenylthio) butadiene (U0126) in rat plasma by liquid chromatography-tandem mass spectrometry
JOURNAL OF SEPARATION SCIENCE 36/2 :239-245,2013

Prognostic Value of Mucinous Histology Depends on Microsatellite Instability Status in Patients with Stage III Colon Cancer Treated with Adjuvant FOLFOX Chemotherapy: A Retrospective Cohort Study
ANNALS OF SURGICAL ONCOLOGY 20/11 :3407-3413,2013

Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma
CANCER CHEMOTHERAPY AND PHARMACOLOGY 72/4 :853-860,2013

Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients
CANCER CHEMOTHERAPY AND PHARMACOLOGY 72/ :825-835,2013

Assessment of efficiency and safety of the comprehensive Chemotherapy Assistance Program for ordering oncology medications
INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS 82/6 :504-513,2013

Changing treatment patterns in elderly patients with resectable colon cancer
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 9/3 :265-272,2013

Combination of CYP Inhibitor with MEK/ERK Inhibitor Enhances the Inhibitory Effect on ERK in BRAF Mutant Colon Cancer Cells
ANTICANCER RESEARCH 33/6 :2499-2508,2013

Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors
SUPPORTIVE CARE IN CANCER 21/6 :1751-1759,2013

Estimating the Adjuvant Chemotherapy Effect in Elderly Stage II and III Colon Cancer Patients in an Observational Study
JOURNAL OF SURGICAL ONCOLOGY 107/6 :613-618,2013

The impact of dermatological toxicities of anti-cancer therapy on the dermatological quality of life of cancer patients
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 27/1 :e53-e59,2013

Circulating vascular endothelial growth factor receptor 2/pAkt-positive cells as a functional pharmacodynamic marker in metastatic colorectal cancers treated with antiangiogenic agent
INVESTIGATIONAL NEW DRUGS 31/1 :1-13,2013

Quantitative Analysis of ERK Signaling Inhibition in Colon Cancer Cell Lines Using Phospho-Specific Flow Cytometry
ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY 34/ :309-316,2012

Application of the Western-based adjuvant online model to Korean colon cancer patients; a single institution experience
BMC CANCER 12/1 :471-471,2012

Implications of clinical risk score to predict outcomes of liver-confined metastasis of colorectal cancer
SURGICAL ONCOLOGY-OXFORD 21/3 :e125-e130,2012

Clinical and Cost Effectiveness of Bevacizumab + FOLFIRI Combination Versus FOLFIRI Alone as First-Line Treatment of Metastatic Colorectal Cancer in South Korea
CLINICAL THERAPEUTICS 34/6 :1408-1419,2012

Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trial
CANCER CHEMOTHERAPY AND PHARMACOLOGY 69/1 :91-97,2012

VIPoma that arose from the rectum in a 65-year-old male patient
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE 27/10 :1385-1386,2012

Treatment Outcome of Patients with Anaplastic Thyroid Cancer: A Single Center Experience
YONSEI MEDICAL JOURNAL 53/2 :352-357,2012

A phase i pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy
INVESTIGATIONAL NEW DRUGS 30/4 :1501-1510,2012

Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer
EUROPEAN RADIOLOGY 22/8 :1693-1700,2012

Response Evaluation in Patients With Colorectal Liver Metastases:RECIST Version 1.1 Versus Modified CT Criteria
AMERICAN JOURNAL OF ROENTGENOLOGY 199/4 :809-815,2012

Weekly Gemcitabine and Docetaxel in Refractory Soft Tissue Sarcoma: A Retrospective Analysis
Cancer Research and Treatment 44/1 :43-49,2012

Detection of liver metastases using gadoxetic-enhanced dynamic and 10- and 20-minute delayed phase MR imaging
JOURNAL OF MAGNETIC RESONANCE IMAGING 35/3 :635-643,2012

A Phase Ib pharmacokinetic study of the anti-angiogenic agent CKD-732 used in combination with capecitabine and oxaliplatin (XELOX) in metastatic colorectal cancer patients who progressed on irinotecan-based chemotherapy
INVESTIGATIONAL NEW DRUGS 30/ :672-680,2012

Adenosine triphosphate-based chemotherapy response assay-guided chemotherapy in unresectable colorectal liver metastasis
BRITISH JOURNAL OF CANCER 106/1 :53-60,2012

DNA Methylation Predicts Recurrence From Resected Stage III Proximal Colon Cancer
CANCER 117/9 :1847-1854,2011

Efficacy of Oxaliplatin-Based Chemotherapy in Curatively Resected Colorectal Cancer with Liver Metastasis
ONCOLOGY 81/3-4 :175-183,2011

Thymidylate synthase gene polymorphism affects the response to preoperative 5-fluorouracil chemoradiation therapy in patients with rectal cancer
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 81/3 :669-676,2011

Comparison of Long-Term Outcome between Doublet and Triplet Neoadjuvant Chemotherapy in Non-Metastatic Osteosarcoma of the Extremity
ONCOLOGY 80/1-2 :107-117,2011

Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer
CANCER CHEMOTHERAPY AND PHARMACOLOGY 68/0 :991-999,2011

Comparison of Diffusion-Weighted MRI and MR Volumetry in the Evaluation of Early Treatment Outcomes After Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer
JOURNAL OF MAGNETIC RESONANCE IMAGING 34/3 :570-576,2011

Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases
RADIATION ONCOLOGY 6/0 :99-99,2011

Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer
INVESTIGATIONAL NEW DRUGS 29/5 :1073-1080,2011

Sunitinib for Asian Patients with Advanced Renal Cell Carcinoma: A Comparable Efficacy with Different Toxicity Profiles
ONCOLOGY 80/5-6 :395-405,2011

Predictive values of 5-fluorouracil pathway genes for S-1 treatment in patients with advanced gastric cancer
ANTI-CANCER DRUGS 22/8 :801-810,2011

A Randomized Phase 2 Study of Docetaxel and S-1 Versus Docetaxel and Cisplatin in Advanced Gastric Cancer With an Evaluation of SPARC Expression for Personalized Therapy
CANCER 117/10 :2050-2057,2011

Brain metastases from colorectal carcinoma: prognostic factors and outcome
JOURNAL OF NEURO-ONCOLOGY 101/ :49-55,2011

A Case of Combined Hepatocellular-Cholangiocarcinoma with Favorable Response to Systemic Chemotherapy
Cancer Research and Treatment 42/4 :235-238,2010

The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study
RADIATION ONCOLOGY 5/ :75-75,2010

Belotecan for relapsing small-cell lung cancer patients initially treated with an irinotecan-containing chemotherapy: A phase II trial
Lung Cancer 70/1 :77-81,2010

A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancer
Investigational New Drugs 28/5 :650-658,2010

Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 136/3 :387-394,2010

Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancer
Radiotherapy And Oncology 95/3 :303-307,2010

A Phase II Study of a Combined Biweekly Irinotecan and Monthly Cisplatin Treatment for Metastatic or Recurrent Gastric Cancer
American Journal of Clinical Oncology-Cancer Clinical Trials 33/1 :56-60,2010

Two Dosages of Oral Fluoropyrimidine S-1 of 35 and 40 mg/m(2) bid: Comparison of the Pharmacokinetic Profiles in Korean Patients with Advanced Gastric Cancer
JAPANESE JOURNAL OF CLINICAL ONCOLOGY 40/1 :29-35,2010

Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients
Cancer Letters 288/1 :124-132,2010

Benefits of Recurrent Colonic Stent Insertion in a Patient with Advanced Gastric Cancer with Carcinomatosis Causing Colonic Obstruction
Yonsei Medical Journal 50/2 :296-299,2009

Brain metastases from hepatocellular carcinoma: prognostic factors and outcome
Journal Of Neuro-Oncology 91/3 :307-313,2009

Treatment outcomes of sunitinib treatment in advanced renal cell carcinoma patients: a single cancer center experience in korea
Cancer Research And Treatment 41/2 :67-72,2009

Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck
CANCER CHEMOTHERAPY AND PHARMACOLOGY 65/1 :27-32,2009

Copy number changes can be a predictor for hemoglobin reduction after S-1 monotherapy in gastric cancer
International Journal Of Oncology 34/3 :787-796,2009

Postoperative adjuvant chemotherapy of gastric cancer: scrutiny into the clinical evidence based on quality assessment of medical literature of randomized controlled trials
CANCER CHEMOTHERAPY AND PHARMACOLOGY 63/5 :919-927,2009

Mobilized CD34(+) cells as a biomarker candidate for the efficacy of combined maximal tolerance dose and continuous infusional chemotherapy and G-CSF surge in gastric cancer
Cancer Letters 270/2 :269-276,2008

The number of residual metastatic lymph nodes following neoadjuvant chemotherapy predicts survival in patients with stage III NSCLC
Lung Cancer 60/3 :393-400,2008

Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancer
Annals Of Oncology 19/6 :1135-1140,2008

Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy
Cancer Chemotherapy And Pharmacology 61/ :309-313,2008

The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancer
Cancer Chemotherapy And Pharmacology 61/ :75-81,2008

Capecitabine and doxorubicin combination chemotherapy as salvage therapy in pretreated advanced gastric cancer
Cancer Chemotherapy And Pharmacology 61/ :157-165,2008

Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer
Radiotherapy And Oncology 87/ :361-366,2008

Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib
JOURNAL OF CLINICAL ONCOLOGY 25/18 :2528-2533,2007

Cetuximab rescue a patient with non-small cell lung cancer from rapid disease progression during chemotherapy
ACTA ONCOLOGICA 46/4 :547-549,2007

A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status
BRITISH JOURNAL OF CANCER 97/ :458-463,2007